Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Meeting News
Octane Examines Changing Refractive Surgery Landscape
The 2025 Octane Ophthalmology Tech Forum examined why lens-based procedures are gaining momentum at the expense of traditional refractive surgery. It also looked at the pivotal role that artificial...
2025-2026 Ophthalmic Meetings Calendar
Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.
EyeDura Wins Two Octane Awards for Sustained-Release Eye Drop Platform
EyeDura Therapeutics earned the judges’ top award during Octane’s capital and growth company presentations, which spotlighted early-stage, high-potential ophthalmic ventures. The company was a favo...
Baruch Kuppermann, MD, PhD, Receives 2025 Roger Steinert, MD, Legacy Award
Baruch Kuppermann, MD, PhD, was honored at the Octane meeting as the recipient of the 2025 Roger Steinert, MD, Legacy Award, which recognizes significant leadership, innovation, and enduring contri...
EyeDura and its Eye Drop Platform Continue to Win Honors from Accelerators
EyeDura Therapeutics reported July 15 that the company had earned the Judges’ Choice and People’s Choice awards at the Octane Ophthalmology Tech Forum, held June 27 in Newport Beach, California. Th...
ARVO Sets Tone for AI-Focused Week With Avatar at Keynote Speech
The 2025 meeting of the Association for Research in Vision and Ophthalmology (ARVO) exceeded atten-dance expectations despite uncertainties sparked by US funding restrictions. The 10,915 attendees ...
ARVO Showcases Manufacturers Looking to Refine Ocular Injections
Big ideas typically dominate the headlines, such as AI, gene therapy, or oculomics, but innovation also happens in small things. The 2025 ARVO meeting displayed a surprising amount of attention to ...
Latest AI Discussions Drill Down to Nuts and Bolts—And Concerns
Artificial intelligence (AI) has been a hot topic at major meetings for several years, stirring up unbridled optimism among industry and clinical attendees alike. The excitement surrounding AI is u...
EVs in Ophthalmology Are All About Disease, Not Driving
EVs are having a moment in ophthalmology, and it has nothing to do with Elon Musk. The EVs that are riveting observers in ophthalmology are extracellular vesicles, and according to Sun Young Lee MD...
Batten Disease Candidate Leads the Way in New Gene Therapy Trials
A presentation by Robert Henderson, MD (UK), on May 8 was a highlight of the many ARVO sessions on gene therapy. Henderson presented interim results from a clinical trial of a gene therapy candidat...
ARVO Attendees Share Concern Over Present and Future of Vision Research
The tidal wave of sudden cuts and restrictions to funding for vision and ophthalmic research cast a long shadow over the 2025 ARVO meeting. They came up formally and informally throughout the six-d...
Eyecelerator Meeting’s Expert Panelists Portray an FDA in Flux
A panel at the Eyecelerator meeting on May 2 ahead of ARVO brought together a deeply experienced and knowledgeable group to examine the recent changes at the US FDA and their impact on the ophthalm...
Innovation and Collaboration Take Center Stage at Eyecelerator Meeting
For the first time, an Eyecelerator meeting preceded the ARVO annual conference, convening on May 2 at the Grand Hyatt Deer Valley in Park City, Utah. The event brought together 363 attendees, incl...
X-Rounds Session Provides Rapid-fire Insights on What’s Hot, What’s Not
A session titled “X-Rounds: Cataract Surgery to the Max” focused on the latest advancements and innovations in refractive cataract surgery. The session was packed, drawing the largest audience of t...
ASCRS Panel Examines Digital Visualization’s Ergonomics and Efficiency
Panelists at an ASCRS symposium on digital visualization in surgery embraced advancements, while addressing longstanding concerns about ergonomics and efficiency. The panel members emphasized minim...
Alcon Emphasizes Efficiency of Unity VCS and CS Systems at ASCRS Launch
Surgeons attending the 2025 ASCRS meeting in Los Angeles dropped by Alcon’s booth for multiple presentations of the new Unity dual-function and cataract machines, rather than gathering in big numbe...
Zeiss’ Veracity Surgery Planner Driving Innovation in Cataract Care
Carl Zeiss Meditec celebrated over 2 million cataract cases planned with Veracity during the ASCRS meeting in Los Angeles. A talk with Kerry Solomon, MD, at the Zeiss booth highlighted the surgical...
Surgeon at Alcon Presentation Looks at Voyager DSLT’s Role in Changing Treatment Landscape
Brian Shafer, MD, was one of the three surgeons who described the recently launched Voyager direct selective laser trabeculoplasty (DSLT) device for glaucoma at Alcon’s booth at the 2025 ASCRS meet...
Alcon Launches PanOptix Pro Trifocal Lens at 2025 ASCRS Meeting
Alcon formally launched the Clareon PanOptix Pro trifocal IOL in various venues at the 2025 ASCRS meeting. Events included booth presentations by Robert Melendez, MD, Morgan Micheletti, MD, Jennife...
Rayner’s Sophi, Zeiss’ Micor 700 Showcased at the 2025 ASCRS Meeting
Rayner and Carl Zeiss Meditec showcased cataract surgical systems at the 2025 ASCRS meeting. UK-based Rayner featured the Sophi ultrasonic phaco machine at its booth. The Sophi is notable for its w...
Humanitarian Outreach Front and Center at 2025 ASCRS Meeting
The opening session at the 2025 ASCRS meeting’s Main Stage event shined a spotlight on humanitarian outreach and the critical mission of supporting global eye care. Francis Mah, MD, the incoming AS...
‘Dr. Glaucomflecken’ Pushes ASCRS Attendees to Harness Social Media, Public Pressure for Change
William Flanary, MD, better known as Dr. Glaucomflecken online, energized the audience at the 2025 ASCRS meeting’s Main Stage event on Sunday as he emphasized the importance of both social media an...
ASCRS Meeting Draws More than 4,600
The ASCRS reported total meeting registration of 4,651 in Los Angeles, with 3,232 ophthalmologists, 749 practice management staff, and 402 attendees categorized as corporate, guests, and other. Sig...
New SightLine Meeting Focuses on Business Acumen Within Industry
The inaugural SightLine at ASCRS meeting, held on April 24 in Los Angeles, convened key stakeholders across the ophthalmic industry to discuss topics such as ophthalmology’s position in the broader...
Cambridge Innovation Institute Absorbs Healthegy’s OIS, OIS Retina Conferences
Cambridge Innovation Institute, of Needham, Massachusetts, announced April 10 that it would expand its health care event calendar by taking on Healthegy’s ophthalmic conferences—the Ophthalmology I...
Alcon Rolls Out Unity VCS and CS Systems at ASCRS Meeting
Alcon announced April 25 the launch of its dual-function Unity Vitreoretinal Cataract System (VCS) and stand-alone Unity Cataract System (CS) in four markets, including the US. The announcement cam...
May 12 is Deadline to Apply for Ramin Tadayoni Award for Research
Applications are open until May 12, 2025, for this year’s Ramin Tadayoni Award, offered by the European Society of Retina Specialists, or Euretina, and supported by Oculis as a tribute to retina sp...
Combined APAO-AIOS Meeting Draws 12,500 to New Convention Center in India
Around 12,500 delegates attended the 2025 joint meeting of the Asia-Pacific Academy of Ophthalmology and All-India Ophthalmolog-ical Society, with more than 1,300 international visitors. The confer...
Asia-Pacific Leads Push to Get AI from the Bench to the Bedside
Bridging the gap between artificial intelligence development and deployment in ophthalmology was the main theme of a Thursday morning session on AI innovation at the 2025 APAO-AIOS meeting. Paisan ...
Indian Glaucoma Surgeons Embrace MIGS Procedures Over Devices
Most MIGS (minimally invasive glaucoma surgery) sessions at major ophthalmic meetings talk about devices. Indian doctors at the MIGS sessions of the joint APAO-AIOS congress in April mostly talked ...
Cambridge Innovation Institute Absorbs Healthegy’s OIS, OIS Retina Conferences
Cambridge Innovation Institute, of Needham, Massachusetts, announced April 10 that it would expand its health care event calendar by taking on Healthegy’s ophthalmic conferences—the Ophthalmology I...
AGS Meeting Features Technology Updates, Voyager DSLT Launch
The 40th Annual American Glaucoma Society (AGS) meeting was highlighted by fast-paced sessions for providers, updates on the latest surgical technology, and the launch of Alcon’s Voyager DSLT. The ...
Meet with Market Scope at the 2025 ASCRS Meeting
Market Scope will be located at Booth No. 1002 at the 2025 ASCRS meeting in April at the Los Angeles Convention Center. Contact us to set up a time to discuss your custom research needs. Reach us a...
ARVO Extends Deadline for Attendees to Meeting to Pay Reduced Fees
The Association for Research in Vision and Ophthalmology (ARVO) announced March 10 that it had extended the deadline for reduced registration fees for its annual meeting. The lower rates are now in...
G360’s New Horizons Forum Highlights Innovations and Discusses the Future of Glaucoma Therapy
The Glaucoma 360 New Horizons Forum provided an update on technologies with high interest, as well as devices just gaining attention. The forum was held Feb. 7 in San Francisco, California, and dre...
Market Scope and the Glaucoma Research Foundation Celebrate 10 Years of Partnership
The handshake agreement over 10 years ago was simple. Market Scope would attend the Glaucoma Research Foundation’s annual three-day Glaucoma 360 meeting, consisting of a fundraising gala, the New H...
Gene Therapies Make Progress Toward Goal of Restoring Sight
Gene therapies again generated buzz at the 2024 AAO meeting—as they have at recent meetings—but perhaps most exciting were reports of a treatment that could partially restore severe vision loss fro...
Zeiss Bolsters Launch of Micor 700 at AAO Meeting With US Surgeons Discussing Adoption
Carl Zeiss Meditec featured its Micor 700 at the 2024 meeting of the American Academy of Ophthalmology in Chicago, Illinois, with presentations that included booth talks by select US surgeons who h...
Ophthalmology Continues to Draw Investors, Eyecelerator Meeting Shows; Retina Stands Out
Ophthalmology remains an appealing investment, driven largely by procedural growth. While hundreds of companies are working toward technology enhancements and innovative therapies, ophthalmology pr...
AI Discussions Surge at Eye Meetings with Aim to Allay Fears, Seek Use Cases
The explosive growth of artificial intelligence has generated both fear and excitement among many in the ophthalmic industry. As technology progresses, so do the conversations at major meetings, wi...
Office-Based Surgery Garners Enthusiasm at 2024 AAO Meeting
Several sessions at the 2024 American Academy of Ophthalmology meeting highlighted the trend of office-based surgery (OBS) and the option of oral sedation among practitioners. The consensus among t...
AAO Puts FDA Deputy Director of Ophthalmology on the Hot Seat
William Boyd, MD, deputy director of ophthalmology at the US FDA’s Office of New Drugs, had a quick answer when asked to name the biggest unmet need in ophthalmology. “We need and want more therapi...
Are Drugs for GA in the ‘Trough of Disillusionment’?
The celebrations and excitement that accompanied the launch in 2023 of the first two drugs approved in the US for the treatment geographic atrophy (GA) gave way to a hangover and regrets at the 202...
Weighing the Ophthalmic Impact of Boom in GLP-1 Receptor Agonist Treatment
Recent studies indicate that up to 6 percent of the US population is currently taking a GLP-1 receptor agonist, a class of drugs prescribed to help manage blood glucose levels for diabetes and weig...
New Trifocal IOLs Expected to Help the US Resume PC-IOL Growth
Bausch + Lomb’s enVista Envy and J&J Vision’s Odyssey are two new trifocal IOLs that were shown at the 2024 AAO meeting in Chicago. They are expected to help reverse the decline in trifocal IOL sal...
AAO and Eyecelerator Sessions Showcase Latest in Glaucoma Lasers and Surgical Devices
New glaucoma lasers and surgical devices were shown at various venues during the 2024 AAO meeting, including Glaucoma Subspecialty Day and the Eyecelerator meeting. There was also an important upda...
Alcon Looks to Refine Retinal Surgery with Unifeye, Unipexy
Alcon launched at the 2024 AAO meeting two new retinal surgical devices—Unifeye for air-gas exchange and Unipexy for retinopexy. Each is a one-person, hand-held, single-use gas delivery device. The...
Cornea and Eye Banking Forum Looks at Ways to Expand the Donor Pool
Expanding the donor pool was once again top of mind at the 2024 Cornea and Eye Banking Forum, held Oct. 18 in conjunction with the AAO meeting in Chicago, Illinois. The forum, supported by the Eye ...
First ASCRS Business Summit Breaks Down Premium Surgery’s Role in Practice Success
The first-ever ASCRS Business of Refractive Cataract Surgery (BRiCS) Summit was a two-day course designed to equip practices with the knowledge, resources, and confidence to boost their adoption of...
ESCRS Congress Boasts Record Attendance in Barcelona
Barcelona, Spain, hosted the ESCRS congress for the third time in the 42-year history of the meeting and set a record for the highest attendance to date. Nearly 17 thousand people registered, 60 pe...
EU Regulators Rain on Apellis’ Party at 2024 Euretina Congress
The big news at the 24th Euretina congress was something that didn’t happen at the congress. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) embarrassed Apelli...
Retina Specialists Grapple with Functional Endpoints in Clinical Trials
European regulators’ repeated rejection of Syfovre made one thing very clear to retina specialists at Euretina: “Treatment should have an impact on everyday function,” said Thomas Ach, MD (Germany)...
Retina Surgeons at European Meetings Ask, ‘What’s New?’
Experienced retina surgeons among the approximately 8.1 thousand attendees at Euretina in Barcelona, Spain, were underwhelmed by the surgical devices that industry had on display. “There is nothing...
ESCRS iNovation Day Looks at MDR Roadblocks, Global Care Issues
The impact of Europe’s new Medical Device Regulation (MDR) on innovation sparked considerable discussion during the ESCRS iNovation Day. The meeting was held Sept. 6 in Barcelona, Spain, ahead of t...
ISOP Meeting Examines Importance of Patient Education and Predictable Outcomes
Patient selection, education, and communication were emphasized throughout the International Society of Presbyopia’s 16th annual conference. The meeting, held Sept. 5 at the Hyatt Regency Hotel in ...
Sustainability: Walking the Walk or Talking the Talk?
Sustainability was a theme for multiple sessions at this year’s ESCRS congress, including one called “Sustainability Without Borders,” hosted by the ESCRS’ Young Ophthalmologists for Sustainability...
Investors Take Temperature of Ophthalmic Market at European Futures Forum
The 2024 Ophthalmology Futures European Forum reviewed the decline in ophthalmic deals in 2024 before offering presenting companies some guidance on how to advance their technology in such an envir...
Hyperopia Treatment Using Lenticule Extraction Showcased to Eager European Ophthalmologists
Dan Reinstein, MD (UK), shared during an overly full symposium at the 2024 ESCRS congress his experience using Zeiss’ SMILE lenticule extraction procedure to treat hyperopic patients. Zeiss is the ...
Cornea Surgeons Examine New Crosslinking Options and Old Debates
Farhad Hafezi, MD, PhD, FARVO (Switzerland), discussed at the 2024 ESCRS congress the goals of the second global consensus on keratoconus, being drafted in 2024. This consensus encompasses feedback...
ESCRS Congress Celebrates 75th Anniversary of First IOL Implantation
The 2024 ESCRS congress celebrated the 75th anniversary of Sir Harold Ridley, MD, implanting the first intraocular lens by telling his story and describing the developments that have occurred since...
2024 ESCRS Congress Puts Spotlight on Latest IOL Designs
New and recently launched IOLs took the spotlight in presentations and on the exhibit floor at the 2024 ESCRS congress. These lenses included the Rayner RayOne Galaxy trifocal, the BVI Serenity Mon...
ViaLase Releases Latest Glaucoma Laser Data at ESCRS Congress
Rick Lewis, MD, chief medical officer at ViaLase, provided an update at the 2024 ESCRS congress on the ViaLuxe glaucoma laser, including the system’s most recent clinical trial results. The ViaLuxe...
Bausch + Lomb Launches Octavius Topo-Guided Treatment at ESCRS Congress
Bausch + Lomb showcased its CE marked Octavius at the 2024 ESCRS Congress. Octavius is a new treatment mode on the Teneo excimer laser that uses data from multiple diagnostic platforms to provide a...
2024 World Ophthalmology Congress Draws Thousands to Vancouver
Nearly 3 thousand attendees from 127 countries participated in the 2024 World Ophthalmology Congress (WOC), the biennial meeting of the International Council of Ophthalmology (ICO). Over 500 attend...
Meet with Market Scope at the 2024 AAO Meeting
Market Scope will be exhibiting at the 2024 AAO meeting, set for Oct. 18-21 at McCormick Place in Chicago. We will be located at Booth 4903. Contact us to set up a time to discuss any custom resear...
Ophthalmologists Compare Myopia Interventions at WOC as Prevalence Soars
Myopia—especially progression of myopia—is getting increased attention from industry and physicians, as evidenced by the sheer number of studies published on the topic. Additionally, data showing h...
Ophthalmologists Address Challenges of Ocular Trauma During WOC Sessions
Eleven sessions, 52 presentations, and numerous posters at the 2024 World Ophthalmology Congress were dedicated to ocular traumas and emergencies. Conflict zones present ophthalmologists and manufa...
WOC Sessions Raise Concerns Over Physician Health as Burnout Increases
Ron Adelman, MD, MPH, MBA (US), shared findings at the 2024 World Ophthalmology Congress from a study that evaluated the level of burnout among ophthalmologists in the Philippines. Results showed t...
Wnt Agonists and Optogenetics Create Excitement at 2024 ASRS Meeting in Sweden
Impressive new science and challenging business conditions topped the discussions at the American Society of Retina Specialists’ 2024 annual meeting. The conference took place July 17-20 in Stockho...
Meet with Market Scope at the 2024 ESCRS Congress
Market Scope will be exhibiting at the 2024 ESCRS congress, which is Sept. 6-10 in Barcelona, Spain. We will be located at Stand 6.D12. Contact us to set up a time to discuss any custom research ne...
2024 Octane Meeting Delves Into Practice Management Issues
The 2024 Octane Ophthalmology Tech Forum changed up its program from previous years, putting more focus on practice management and moving to a new location: the VEA Newport Beach, in Newport Beach,...
Eye Banking Meeting Celebrates Successful Transplants, Looks at Needs Going Forward
Attendees at the 2024 Eye Banking Association of America (EBAA) meeting celebrated many achievements and milestones across the eye banking profession and transplant community in general, as 2023 ma...
Champalimaud Vision Award Recognizes Eye Hospital Serving Gaza and West Bank
A sparsely attended Champalimaud Vision Award Lecture at the 2024 ARVO meeting highlighted the work of St. John of Jerusalem Eye Hospital in Gaza, Jerusalem, and the West Bank. Leonor Beleza, presi...
2024 ARVO Meeting Sets Attendance Record, Showcases Novel Treatment Approaches
The 2024 meeting of the Association for Research in Vision and Ophthalmology set a record as the largest ARVO meeting ever. The 11,631 registered attendees passed the old record of 10,224 set in Va...
Ophthalmic Companies Use ARVO Meeting to Boost Research
Many companies participate in ARVO’s annual meeting to catch the attention of external researchers and propel their research program or clinical trials forward. Two such companies in 2024 were John...
Artificial Intelligence Takes Leading Role at 2024 ARVO Meeting
Artificial intelligence was a prominent topic at the 2024 ARVO meeting. Discussions ranged from using AI in published ophthalmic research to employing it in early detection and monitoring of eye di...
2024 ARVO Awards Highlight New Focus on Inflammation
The Weisenfeld and Cogan awards and lectures at the 2024 ARVO meeting put a spotlight on inflammation. Martine Jager, MD, PhD (Netherlands), received the Weisenfeld Award in recognition of her pion...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.